Teva Pharmaceutical Industries competitive analysis

Explore patent oppositions filed by Teva Pharmaceutical Industries against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition Date
Methods Of Treating Hfpef Employing Dapagliflozin And Compositions Comprising The SameASTRAZENECAJul 15, 2026
Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen DiseasesTRAVERE THERAPEUTICSJun 30, 2026
Formulations Of Ag10EIDOS THERAPEUTICSJun 23, 2026
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 9, 2026
Methods Of Selecting A Treatment For Cancer PatientsNOVARTISJun 2, 2026
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 2, 2026
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 19, 2026
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSApr 15, 2026
Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARMApr 7, 2026
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 2, 2026

Explore Teva Pharmaceutical Industries's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 6, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 13, 2024Medical Injection Device Packaging2
Mar 22, 2017Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate2

Latest PTAB cases involving Teva Pharmaceutical Industries

Discover the latest PTAB cases involving Teva Pharmaceutical Industries, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Teva Pharmaceutical Industries with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TEVA PHARMACEUTICALS224181712
BOEHRINGER INGELHEIM3418389
JANSSEN PHARMACEUTICA165 - 1
NOVARTIS6472 - 21